A comparative analysis of boosting algorithms for chronic liver disease prediction

Shahid Mohammad Ganie , Pijush Kanti Dutta Pramanik
{"title":"A comparative analysis of boosting algorithms for chronic liver disease prediction","authors":"Shahid Mohammad Ganie ,&nbsp;Pijush Kanti Dutta Pramanik","doi":"10.1016/j.health.2024.100313","DOIUrl":null,"url":null,"abstract":"<div><p>Chronic liver disease (CLD) is a major health concern for millions of people all over the globe. Early prediction and identification are critical for taking appropriate action at the earliest stages of the disease. Implementing machine learning methods in predicting CLD can greatly improve medical outcomes, reduce the burden of the condition, and promote proactive and preventive healthcare practices for those at risk. However, traditional machine learning has some limitations which can be mitigated through ensemble learning. Boosting is the most advantageous ensemble learning approach. This study aims to improve the performance of the available boosting techniques for CLD prediction. Seven popular boosting algorithms of Gradient Boosting (GB), AdaBoost, LogitBoost, SGBoost, XGBoost, LightGBM, and CatBoost, and two publicly available popular CLD datasets (Liver disease patient dataset (LDPD) and Indian liver disease patient dataset (ILPD)) of dissimilar size and demography are considered in this study. The features of the datasets are ascertained by exploratory data analysis. Additionally, hyperparameter tuning, normalisation, and upsampling are used for predictive analytics. The proportional importance of every feature contributing to CLD for every algorithm is assessed. Each algorithm's performance on both datasets is assessed using k-fold cross-validation, twelve metrics, and runtime. Among the five boosting algorithms, GB emerged as the best overall performer for both datasets. It attained 98.80% and 98.29% accuracy rates for LDPD and ILPD, respectively. GB also outperformed other boosting algorithms regarding other performance metrics except runtime.</p></div>","PeriodicalId":73222,"journal":{"name":"Healthcare analytics (New York, N.Y.)","volume":"5 ","pages":"Article 100313"},"PeriodicalIF":0.0000,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772442524000157/pdfft?md5=b2782e61e17bafe88b65e8e663f21da2&pid=1-s2.0-S2772442524000157-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Healthcare analytics (New York, N.Y.)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772442524000157","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Chronic liver disease (CLD) is a major health concern for millions of people all over the globe. Early prediction and identification are critical for taking appropriate action at the earliest stages of the disease. Implementing machine learning methods in predicting CLD can greatly improve medical outcomes, reduce the burden of the condition, and promote proactive and preventive healthcare practices for those at risk. However, traditional machine learning has some limitations which can be mitigated through ensemble learning. Boosting is the most advantageous ensemble learning approach. This study aims to improve the performance of the available boosting techniques for CLD prediction. Seven popular boosting algorithms of Gradient Boosting (GB), AdaBoost, LogitBoost, SGBoost, XGBoost, LightGBM, and CatBoost, and two publicly available popular CLD datasets (Liver disease patient dataset (LDPD) and Indian liver disease patient dataset (ILPD)) of dissimilar size and demography are considered in this study. The features of the datasets are ascertained by exploratory data analysis. Additionally, hyperparameter tuning, normalisation, and upsampling are used for predictive analytics. The proportional importance of every feature contributing to CLD for every algorithm is assessed. Each algorithm's performance on both datasets is assessed using k-fold cross-validation, twelve metrics, and runtime. Among the five boosting algorithms, GB emerged as the best overall performer for both datasets. It attained 98.80% and 98.29% accuracy rates for LDPD and ILPD, respectively. GB also outperformed other boosting algorithms regarding other performance metrics except runtime.

用于慢性肝病预测的增强算法比较分析
慢性肝病(CLD)是全球数百万人的主要健康问题。早期预测和识别对于在疾病的早期阶段采取适当行动至关重要。采用机器学习方法预测慢性肝病可以大大改善医疗效果,减轻病情负担,并促进高危人群采取积极的预防性保健措施。然而,传统的机器学习存在一些局限性,而通过集合学习可以缓解这些局限性。集群学习(Boosting)是最有优势的集群学习方法。本研究旨在提高现有助推技术在 CLD 预测中的性能。本研究考虑了梯度提升(GB)、AdaBoost、LogitBoost、SGBoost、XGBoost、LightGBM 和 CatBoost 七种流行的提升算法,以及两个公开的流行 CLD 数据集(肝病患者数据集 (LDPD) 和印度肝病患者数据集 (ILPD)),这两个数据集的规模和人口统计学特征各不相同。数据集的特征是通过探索性数据分析确定的。此外,超参数调整、归一化和上采样被用于预测分析。评估了每种算法的每个特征对 CLD 的重要性比例。使用 k 倍交叉验证、12 个指标和运行时间评估了每种算法在两个数据集上的性能。在五种提升算法中,GB 在两个数据集上的整体表现最佳。它对 LDPD 和 ILPD 的准确率分别达到了 98.80% 和 98.29%。除运行时间外,GB 在其他性能指标上也优于其他提升算法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Healthcare analytics (New York, N.Y.)
Healthcare analytics (New York, N.Y.) Applied Mathematics, Modelling and Simulation, Nursing and Health Professions (General)
CiteScore
4.40
自引率
0.00%
发文量
0
审稿时长
79 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信